Indian Immunologicals likely to start Covaxin production in a month

Indian Immunologicals likely to start Covaxin production in a month

This plant would make an additional six million units of the Covaxin. Indian Immunologicals (IIL), a public sector enterprise, will start manufacturing and supplying Covid-19 vaccines by the end of August or early September from its facility in Hyderabad. This would augment production of Bharat Biotech’s Covaxin vaccine in the country. V K Paul, member, … Read more

Covaxin interim efficacy very good, awaiting more data and full results: Dr Gagandeep Kang

Covaxin interim efficacy very good, awaiting more data and full results: Dr Gagandeep Kang

These countries are highly satisfied with the safe, inactivated vaccine technology and robust data package for safety and immunogenicity.” The much-awaited result from the phase 3 clinical trials of Covaxin, the vaccine that has been granted emergency use authorization under a trial mode, is finally out and the news seems encouraging. What is however awaited … Read more